Applied Molecular Transport Inc.: Nasdaq/NYSE listing notice — Applied Molecular Transport receives Nasdaq delisting notice for bid price non-compliance

Applied Molecular Transport Inc.

Nasdaq notified AMTI on Feb. 8, 2023, that its stock failed to maintain minimum $1.00 closing bid price for 30 consecutive business days.
Company has 180 calendar days from Notice to regain compliance; a second 180-day period may be available if conditions met.
To regain compliance, closing bid price must be at least $1.00 for ten consecutive business days during compliance period.
If unable to regain compliance, stock could be delisted from Nasdaq Global Select Market.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Applied Molecular Transport Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5450(a)(1)

Exact text from the filing

February 8, 2023, Applied Molecular Transport Inc. (the “Company”) received a written notice from the Listing Qualifications Staff of the Nasdaq Stock Market (“Nasdaq”) notifying the Company that it has not been in compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5450(a)(1) for a period of 30 consecutive business days (the “Notice”). This Notice has no immediate effect on the listing of the Company’s stock on the Nasdaq Global Select Market. In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company is provided a compliance period of 180 calendar days f

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001193125-23-030004

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.